[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.163.94.5. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
April 1986

HTLV-III Antibody in Intravenous Drug Abusers of Metropolitan Barcelona, Spain

Author Affiliations

Barcelona, Spain

Arch Intern Med. 1986;146(4):805. doi:10.1001/archinte.1986.00360160261039
Abstract

To the Editor.  —The presence of antibodies to human T-cell lymphotropic virus type III (HTLV-III) has been studied in patients affected by acquired immunodeficiency syndrome (AIDS), AIDS-related complex, lymphadenopathy syndrome, in symptom-free individuals at high risk of developing AIDS, and in the general population." The presence of antibodies to HTVL-III in intravenous drug abusers (IDAs) has been reported as showing great geographic differences, from 87% in the United States5 to 1.5% in the United Kingdom.3In this letter, we report the preliminary results of a study of 92 consecutive heterosexual IDAs who were residents of metropolitan Barcelona, Spain, and admitted to our hospital because of infectious complications or for treatment of their drug addiction.All HTLV-III seropositive and sero-negative IDAs usually shared needles on more than one occasion. All patients were living in metropolitan Barcelona during their drug-abuse period. It is very improbable that they used needles from

First Page Preview View Large
First page PDF preview
First page PDF preview
×